Restoring sodium iodide symporter (NIS) expression and function remains a major challenge for radioiodine therapy in anaplastic thyroid cancer (ATC). This evidence concerns the gene SLC5A5 and thyroid gland undifferentiated (anaplastic) carcinoma.